The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary
Guideline Objective
At the request of the Ontario PET Steering Committee, literature pertaining to the utility of PET/CT in the clinical management of patients with extrahepatic colorectal cancer metastasis was summarized.
Patient Population
Patients with new or recurrent colorectal cancer who are potentially eligible for surgical resection of extrahepatic metastasis.
Intended Guideline Users
To guide the Ontario PET Steering Committee in their decision making concerning indications for the use of PET imaging. This evidence summary may also be useful in informing clinical decision making regarding the appropriate role of PET imaging and in guiding priorities for future PET imaging research.
Research Question(s)
In patients with colorectal cancer, what is the role of fluorodeoxyglucose (FDG) PET/CT in determining suitability for surgical removal for isolated lung and abdominal (nodal) metastasis?
